比索洛尔对冠心病患者血浆C反应蛋白的影响

被引：5

作者：

王邦宁

张凤祥

宋兵

陈大年

刘和俊

刘敏

骆志刚

机构：

[1] 安徽医科大学第一附属医院心内科

来源：

中国临床保健杂志 | 2005年 / 02期

关键词：

比索洛尔; 冠状动脉疾病; 血浆C反应蛋白;

D O I：

暂无

中图分类号：

R541.4 [冠状动脉（粥样）硬化性心脏病（冠心病）];

学科分类号：

摘要：

目的　探讨比索洛尔对冠心病患者血浆C反应蛋白(CRP)的影响。方法　将冠心病稳定型心绞痛患者随机分成A、B、C三组:治疗组(A组)、病例对照组(B组) ,另设正常对照组(C组)。结果　A、B组较C组明显升高(P <0 .0 1) ,A组服用比索洛尔后血浆CRP水平明显降低(P <0 .0 5 )。结论　比索洛尔明显降低冠心病稳定性心绞痛患者血浆CRP浓度。

引用

页码：97 / 99

页数：3

共 8 条

[1]

Catecholamines upregulate lippolysaccharide-induced IL-6 production in human microvascular endo thelial cells. Gornikiewicz A,Sautner T,Brostjan C,et al. The FASEB Journal . 2000

[2]

The effect of pravastain on coronary events after mvocardial infarction in patients with average cholesterol level. Sachs FM,Pteffer MA,Moye LA,et al. The New England Journal of Medicine . 1996

[3]

Betanblockers are associated with lower C-reactive protien concemtrations in pations with coronary atery disease. Nicholas P,Jenkin S,MB chB,et al. The American Journal of Medicine . 2002

[4]

C-reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. Mendall MA,Patel P,Ballam L,et al. British Medical Journal . 1996

[5]

Inflammatory markers in men with angiographically documented coronary heart disease. Rifai N,Joubran R,Yu H,et al. Clin-Chem . 1999

[6]

Inflammation, asprin, and the risk of cardiovascular disease in apparently healthy men. Ridker PM,Cushman M,Stampfer MJ,et al. The New England Journal of Medicine . 1997

[7]

Plasma concentration of and risk of developing peripheral vascular disease. Ridker PM,Cushman M,Stampfer MJ,et al. Circulation . 1998

[8]

Norepinephrine stimulates interleukin-6 mRNA expression in primary cultured rat hepatocytes. Jung BD,Kimura K,Kitamura H,et al. Journal of Biochemistry . 2000

← 1 →